Kronish L - Search Results

1

Docetaxel and carboplatin as first-line therapy in advanced non-small cell lung carcinoma: a phase II study.

Jahanzeb M, Sarna G, Hirsch R, Radice P, Koletsky A, Martinez M, Kruglyak E, Wolin E, Camacho E, Kronish L, Motl S. Jahanzeb M, et al. Among authors: kronish l. Anticancer Res. 2004 Mar-Apr;24(2C):1239-42. Anticancer Res. 2004. PMID: 15154653 Free article. Clinical Trial.

2

Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.

Jahanzeb M, Mortimer JE, Yunus F, Irwin DH, Speyer J, Koletsky AJ, Klein P, Sabir T, Kronish L. Jahanzeb M, et al. Among authors: kronish l. Oncologist. 2002;7(5):410-7. doi: 10.1634/theoncologist.7-5-410. Oncologist. 2002. PMID: 12401903 Free article. Clinical Trial.

3

Phase II study of vinorelbine and low-dose docetaxel in chemotherapy-naive patients with hormone-refractory prostate cancer.

Koletsky AJ, Guerra ML, Kronish L. Koletsky AJ, et al. Among authors: kronish l. Cancer J. 2003 Jul-Aug;9(4):286-92. doi: 10.1097/00130404-200307000-00011. Cancer J. 2003. PMID: 12967139 Clinical Trial.

4

Does race affect outcomes in triple negative breast cancer?

Sachdev JC, Ahmed S, Mirza MM, Farooq A, Kronish L, Jahanzeb M. Sachdev JC, et al. Among authors: kronish l. Breast Cancer (Auckl). 2010 May 7;4:23-33. Breast Cancer (Auckl). 2010. PMID: 20697530 Free PMC article.

5

Intensive dose ifosfamide, carboplatin, and etoposide followed by autologous stem cell rescue: results of a phase I/II study in breast cancer patients.

Fields KK, Perkins JP, Hiemenz JW, Zorsky PE, Janssen WE, Kronish LE, Machak MC, Elfenbein GJ. Fields KK, et al. Among authors: kronish le. Surg Oncol. 1993;2(1):87-95. doi: 10.1016/0960-7404(93)90049-5. Surg Oncol. 1993. PMID: 7902764 Clinical Trial.

6

Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.

Osarogiagbon RU, Sachdev JC, Khattak AG, Kronish LE. Osarogiagbon RU, et al. Among authors: kronish le. Clin Colorectal Cancer. 2009 Apr;8(2):94-9. Clin Colorectal Cancer. 2009. PMID: 19739270

7

Ifosfamide, carboplatin, and etoposide: a new regimen with a broad spectrum of activity.

Fields KK, Zorsky PE, Hiemenz JW, Kronish LE, Elfenbein GJ. Fields KK, et al. Among authors: kronish le. J Clin Oncol. 1994 Mar;12(3):544-52. doi: 10.1200/JCO.1994.12.3.544. J Clin Oncol. 1994. PMID: 8120552 Clinical Trial.

8

A retrospective study evaluating a fixed low dose capecitabine monotherapy in women with HER-2 negative metastatic breast cancer.

Ambros T, Zeichner SB, Zaravinos J, Montero AJ, Ahn E, Aruna M, Kronish L, Mahtani RL, Vogel CL. Ambros T, et al. Among authors: kronish l. Breast Cancer Res Treat. 2014 Jul;146(1):7-14. doi: 10.1007/s10549-014-3003-x. Epub 2014 Jun 5. Breast Cancer Res Treat. 2014. PMID: 24899084 Review.

9

High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.

Fields KK, Elfenbein GJ, Perkins JB, Janssen WE, Ballester OF, Hiemenz JW, Zorsky PE, Kronish LE, Foody MC. Fields KK, et al. Among authors: kronish le. Semin Oncol. 1994 Oct;21(5 Suppl 12):86-92. Semin Oncol. 1994. PMID: 7527592 Clinical Trial.

10

Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.

Fields KK, Elfenbein GJ, Perkins JB, Hiemenz JW, Janssen WE, Zorsky PE, Ballester OF, Kronish LE, Foody MC. Fields KK, et al. Among authors: kronish le. Semin Oncol. 1993 Oct;20(5 Suppl 6):59-66. Semin Oncol. 1993. PMID: 8211217 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters